EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy

Ying Zhao, Yubo Lu, Yushan Ma, Sijia Wang, Pin Lv, Huifang Xu, Yuanyuan Li, Weisheng Feng iD

Molecules · 10.02.2026 · 31 (4) · 621

DOI: 10.3390/molecules31040621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 10.02.2026. Verfasst von Ying Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China. Hauptthemen laut MEDLINE: Berberine, Coumaric Acids, Nanomedicine, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the China Postdoctoral Science Foundation, the Natural Science Foundation of Henan Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer ranks among the most prevalent malignant tumors globally, underscoring the urgent need for efficient and low-toxicity treatment strategies. In this study, a novel nanomedicine (BBR-SA) was constructed based on the self-assembled of berberine (BBR) and sinapic acid (SA) for synergistic chemotherapy. Firstly, utilizing π-π stacking, hydrogen bonding, and electrostatic forces between BBR and SA, the BBR-SA achieved a well-defined nanostructure with high drug-loading capacity and favorable water dispersibility. Furthermore, BBR-SA nanomedicine effectively inhibited the proliferation of mouse mammary carcinoma cells (4T1), showing a significantly stronger inhibitory effect than either BBR or SA alone. Moreover, the remarkable anti-tumor effect was obtained after treatment with BBR-SA nanomedicine in vivo, further demonstrating a synergistic therapeutic effect. More importantly, no significant systemic toxicity was observed after 28 days of intravenous administration with BBR-SA nanomedicine. In summary, the BBR-SA nanomedicine represents a safe and effective therapeutic strategy for breast cancer, offering new perspectives on the application of the traditional chinese medicine in anti-tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineCoumaric AcidsNanomedicineAntineoplastic AgentsAnimalsMiceFemaleDrug SynergismCell Line, TumorCell ProliferationHumansNanoparticles

Stichwörter der Autor:innen

berberineself-assemblysinapic acidsynergistic chemotherapytraditional chinese medicine

Substanzen

BerberineCoumaric Acidssinapinic acidAntineoplastic Agents

Autor:innen und Institutionen

  • College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.

ORCID-Profile: Weisheng Feng

Förderung

  • the China Postdoctoral Science Foundation
  • the Natural Science Foundation of Henan Province
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Henan Province

Zitieren

APA

Zhao, Y., Lu, Y., Ma, Y., Wang, S., Lv, P., Xu, H., Li, Y., & Feng, W. (2026). Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy. Molecules, 31(4), 621. https://doi.org/10.3390/molecules31040621

Vancouver

Zhao Y, Lu Y, Ma Y, Wang S, Lv P, Xu H, et al. Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy. Molecules. 2026;31(4):621. doi:10.3390/molecules31040621

BibTeX
@article{Zhao2026,
  author = {Zhao, Ying and Lu, Yubo and Ma, Yushan and Wang, Sijia and Lv, Pin and Xu, Huifang and Li, Yuanyuan and Feng, Weisheng},
  title = {Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {4},
  pages = {621},
  doi = {10.3390/molecules31040621}
}
Kostenlos starten →